150 related articles for article (PubMed ID: 27173475)
1. Diagnostic Impacts of Serum CA-125 Levels, Pap Smear Evaluation, and Endometrial Sampling in Women with Endometrial Clear Cell Carcinoma.
Cetinkaya N; Selcuk İ; Ozdal B; Meydanli MM; Gungor T
Oncol Res Treat; 2016; 39(5):283-8. PubMed ID: 27173475
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in endometrial clear cell carcinoma.
Cetinkaya N; Selcuk İ; Ozdal B; Meydanli MM; Gungor T
Arch Gynecol Obstet; 2017 Jan; 295(1):189-195. PubMed ID: 27549092
[TBL] [Abstract][Full Text] [Related]
3. Precursors of endometrial clear cell carcinoma.
Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
[TBL] [Abstract][Full Text] [Related]
4. Preoperative CA 125 tumour marker in endometrial cancer: correlation with advanced stage disease.
Sebastianelli A; Renaud MC; Grégoire J; Roy M; Plante M
J Obstet Gynaecol Can; 2010 Sep; 32(9):856-860. PubMed ID: 21050518
[TBL] [Abstract][Full Text] [Related]
5. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.
Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345
[TBL] [Abstract][Full Text] [Related]
6. Validation of serum biomarkers for detection of early- and late-stage endometrial cancer.
Farias-Eisner G; Su F; Robbins T; Kotlerman J; Reddy S; Farias-Eisner R
Am J Obstet Gynecol; 2010 Jan; 202(1):73.e1-5. PubMed ID: 19766980
[TBL] [Abstract][Full Text] [Related]
7. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma].
Zhang AM; Zhang P
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Analysis of the Tissue Factor Pathway Inhibitor-2 in Endometrial Clear Cell Carcinoma: A Single-center Retrospective Study.
Kawaguchi R; Maehana T; Sugimoto S; Kawahara N; Iwai K; Yamada Y; Kimura F
Int J Gynecol Pathol; 2024 Jan; 43(1):25-32. PubMed ID: 37255450
[TBL] [Abstract][Full Text] [Related]
9. TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer.
Peters-Engl C; Buxbaum P; Ogris E; Sevelda P; Medl M
Anticancer Res; 1998; 18(6B):4635-9. PubMed ID: 9891532
[TBL] [Abstract][Full Text] [Related]
10. Survival outcomes and the prognostic significance of clinicopathological features in patients with endometrial clear cell carcinoma: a 35-year single-center retrospective study.
Ma X; Cao D; Zhou H; Wang T; Wang J; Zhang Y; Yu M; Cheng N; Peng P; Yang J; Huang H; Shen K
World J Surg Oncol; 2023 Mar; 21(1):106. PubMed ID: 36973753
[TBL] [Abstract][Full Text] [Related]
11. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy.
Moolthiya W; Yuenyao P
Asian Pac J Cancer Prev; 2009; 10(5):865-8. PubMed ID: 20162854
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum CA 125 level in the prediction of the stage of disease in endometrial carcinoma.
Yildiz A; Yetimalar H; Kasap B; Aydin C; Tatar S; Soylu F; Yildiz FS
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):191-5. PubMed ID: 22727919
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
Jiang T; Huang L; Zhang S
BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
[TBL] [Abstract][Full Text] [Related]
14. [Value of gynecological cytology and CA 125 level for the prediction of extrauterine malignancy in endometrial cancer].
Brassard L; Bessette P
J Obstet Gynaecol Can; 2012 Jul; 34(7):657-63. PubMed ID: 22742485
[TBL] [Abstract][Full Text] [Related]
15. [Value of (18)F-FDG imaging and serum tumor markers in the diagnosis of recurrent endometrial carcinoma].
Wang Q; Hong L; Wang JL; Yue MG; Li HB; Li Y
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):300-3. PubMed ID: 20510085
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of tumour specific growth factor (TSGF) and carbohydrate antigen-125 (CA-125) in carcinoma of the endometrium.
Yu B; Xu PZ; Wang QW; Zhou H; Zhou HX
J Int Med Res; 2009; 37(3):878-83. PubMed ID: 19589273
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.
Diefenbach CS; Shah Z; Iasonos A; Barakat RR; Levine DA; Aghajanian C; Sabbatini P; Hensley ML; Konner J; Tew W; Spriggs D; Fleisher M; Thaler H; Dupont J
Gynecol Oncol; 2007 Feb; 104(2):435-42. PubMed ID: 17023034
[TBL] [Abstract][Full Text] [Related]
18. PD-L1/PD-1 Expression in Endometrial Clear Cell Carcinoma: A Potential Surrogate Marker for Clinical Trials.
Jin C; Hacking S; Liang S; Nasim M
Int J Surg Pathol; 2020 Feb; 28(1):31-37. PubMed ID: 31311367
[No Abstract] [Full Text] [Related]
19. Preoperative serum CA-125 levels in treating endometrial cancer.
Powell JL; Hill KA; Shiro BC; Diehl SJ; Gajewski WH
J Reprod Med; 2005 Aug; 50(8):585-90. PubMed ID: 16220763
[TBL] [Abstract][Full Text] [Related]
20. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL
Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
